RecruitingNCT05525962

Vulnerability/Resilience Factors Influencing the Developmental Trajectories and Adaptive Methods of Children and Adolescents in Child Welfare System.

Facteurs de vulnérabilité/résilience influençant Les Trajectoires développementales et Les modalités Adaptatives d'Enfants et d'Adolescents confiés à l'Aide Sociale à l'Enfance. Cohorte Primo-arrivants.


Sponsor

University Hospital, Rouen

Enrollment

300 participants

Start Date

Sep 29, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Assess the prevalence of medico-psychological characteristics at the time of placement (M0), their appearance / disappearance and during the two years following placement (M12 and M24) by age group in children / adolescents in Child Protective Services and placed full-time in the structures of Seine-Maritime and Eure as well as in nursery in Le Havre or Rouen


Eligibility

Max Age: 16 Years

Inclusion Criteria2

  • Minor adressed to child protective services
  • Minor placed full time

Exclusion Criteria5

  • Non affiliation to social security system
  • Non accompanied minor
  • Minor and/or parfents not understanding french
  • Minor informed and refused participation
  • Parents or tutor having refused participation of their child

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALquestionnaries, scales, cognitive tests

A first interview is planned with a psycholgist in the weeks following the minor arrival in the structure (M0) * M0: cognitive test, psychiatric classification and psychologic assessments * M12 and M24: psychiatric classification and psychologic assessments


Locations(5)

IDEFHI

Canteleu, France

Foyer Départementale de l'Enfance

Évreux, France

Centre infantile Raymond Lerch

Le Havre, France

Centre hospitalier du Belvédère

Mont-Saint-Aignan, France

Fondation les Nids

Mont-Saint-Aignan, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05525962


Related Trials